BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 11526696)

  • 1. Reflex human papillomavirus DNA testing on residual liquid-based (TPPT) cervical samples: focus on age-stratified clinical performance.
    Sarode VR; Werner C; Gander R; Foster B; Fulmer A; Saboorian MH; Ashfaq R
    Cancer; 2003 Jun; 99(3):149-55. PubMed ID: 12811855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
    Walker JL; Wang SS; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
    Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
    Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
    Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
    Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HPV testing in patients with possible high-grade cervical cytology.
    Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
    J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
    Layfield LJ; Qureshi MN
    Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
    Bansal M; Austin RM; Zhao C
    Gynecol Oncol; 2009 Nov; 115(2):257-61. PubMed ID: 19665217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus.
    Barzon L; Pizzighella S; Corti L; Mengoli C; Palù G
    J Med Virol; 2002 Jul; 67(3):401-5. PubMed ID: 12116034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
    Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of abnormal cervical smears: management of ASCUS cervical smears].
    Benmoura D; Cravello L; Roger V; Blanc B
    Contracept Fertil Sex; 1999 Mar; 27(3):178-82. PubMed ID: 10334068
    [No Abstract]   [Full Text] [Related]  

  • 16. Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study.
    Inhorn SL; Wand PJ; Wright TC; Hatch KD; Hallum J; Lentrichia BB
    J Reprod Med; 2001 Mar; 46(3):237-42. PubMed ID: 11304865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PAP Class II in gynecology].
    Paavonen J
    Duodecim; 1993; 109(16):1385-9. PubMed ID: 7720597
    [No Abstract]   [Full Text] [Related]  

  • 18. HPV detection in 'large-cell acanthomas': a word of caution.
    Lora V; Kanitakis J
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1468-9. PubMed ID: 19754660
    [No Abstract]   [Full Text] [Related]  

  • 19. [Typification of HPV in clinical practice].
    Wiesenfeld U; Comar M; D'Agaro P; Grimaldi E; Guaschino S; Campello C
    Minerva Ginecol; 2000 Dec; 52(12 Suppl 1):92-6. PubMed ID: 11526696
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.